Protonix and Platelet count abnormal - a phase IV clinical study of FDA data

Summary:

Platelet count abnormal is reported as a side effect among people who take Protonix (pantoprazole sodium), especially for people who are female, 60+ old, also take Jakafi, and have Polycythaemia vera.

The phase IV clinical study analyzes which people have Platelet count abnormal when taking Protonix. It is created by eHealthMe based on reports of 130,073 people who have side effects when taking Protonix from the FDA, and is updated regularly.

What is Protonix?

Protonix has active ingredients of pantoprazole sodium. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 132,658 Protonix users. Check the latest studies of Protonix.

What is Platelet count abnormal?

Platelet count abnormal is found to be associated with 540 drugs and 589 conditions by eHealthMe. Check the latest studies of Platelet count abnormal.

On Jul, 25, 2026

130,073 people reported to have side effects when taking Protonix.
Among them, 85 people (0.07%) have Platelet count abnormal.

Could Protonix cause Platelet count abnormal?

Among these 85 people:

What is the gender of people who have Platelet count abnormal when taking Protonix? *

female: 51.56 %
male: 48.44 %

What is the age of people who have Platelet count abnormal when taking Protonix? *

What are other drugs people take besides Protonix? *

What are other side effects people have besides Platelet count abnormal? *

Fatigue (feeling of tiredness): 20 people, 23.53%
Haemoglobin Decreased: 19 people, 22.35%
Weakness: 16 people, 18.82%
Haematocrit Decreased: 15 people, 17.65%
Haematocrit: 14 people, 16.47%
Weight Decreased: 13 people, 15.29%
Diarrhea: 10 people, 11.76%
Febrile Neutropenia (fever with reduced white blood cells): 10 people, 11.76%
Hypotension (abnormally low blood pressure): 10 people, 11.76%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 9 people, 10.59%

What are the existing conditions these people have? *

Polycythaemia Vera (blood disorder in which the bone marrow makes too many red blood cells): 13 people, 15.29%
Pain: 10 people, 11.76%
Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 6 people, 7.06%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 6 people, 7.06%
Primary Myelofibrosis (primary disorder of the bone marrow): 5 people, 5.88%
Nausea (feeling of having an urge to vomit): 5 people, 5.88%
Hypersensitivity: 4 people, 4.71%
Idiopathic Thrombocytopenic Purpura (Itp) (bleeding disorder in which the immune system destroys platelets, which are necessary for normal blood clotting): 4 people, 4.71%
Lung Cancer - Non-Small Cell (lung cancer): 4 people, 4.71%
Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 4 people, 4.71%

* Approximation only. Some reports may have incomplete information.

Do you take Protonix and have Platelet count abnormal?

- Check whether Platelet count abnormal is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Protonix:

Protonix (132,658 reports)

Browse all side effects of Protonix:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Platelet count abnormal:

Platelet count abnormal (540 drugs)

Browse all the conditions that are associated with Platelet count abnormal:

Platelet count abnormal (589 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on pantoprazole sodium (the active ingredients of Protonix) and Protonix (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.